Genolution Inc. (KOSDAQ:225220)

Market Cap	43.75B
Revenue (ttm)	7.14B
Net Income (ttm)	-6.83B
Shares Out	19.19M
EPS (ttm)	-378.00
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	20,527
Average Volume	32,391
Open	2,205.00
Previous Close	2,200.00
Day's Range	2,190.00 - 2,240.00
52-Week Range	1,980.00 - 5,140.00
Beta	0.59
RSI	53.09
Earnings Date	May 15, 2025

About Genolution

Genolution Inc. manufactures and sells IVD products in South Korea and internationally. Its products are primarily focused on molecular diagnostics, ribonucleic acid interference (RNAi) services, and dsRNA research for the prevention of breeding and extermination. The company offers Nextractor, an automatic extraction system for isolation of DNA or RNA from various samples; and FFPE, whole blood, buccal swab, RV, TB/NTM, STD, HPV, HBV, and CMV/EBV extraction kits, as well as rice, plant, and cell extraction kits. It also provides siRNA/shRNA sy...

• Industry: Surgical and Medical Instruments and Apparatus
• Founded: 2006
• Country: South Korea
• Stock Exchange: KOSDAQ
• Ticker Symbol: 225220

Financial Performance

In 2024, Genolution's revenue was 7.14 billion, a decrease of -26.90% compared to the previous year's 9.76 billion. Losses were -6.83 billion, 23.8% more than in 2023.